Skip to main content
Gut logoLink to Gut
. 1999 Aug;45(2):295–300. doi: 10.1136/gut.45.2.295

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

Z Younossi 1, G Guyatt 1, M Kiwi 1, N Boparai 1, D King 1
PMCID: PMC1727607  PMID: 10403745

Abstract

BACKGROUND AND AIMS—To develop and assess a disease specific instrument for measuring health related quality of life (HRQL) in patients with chronic liver disease (CLD).
METHODS—Based on responses from 60 patients with chronic liver disease, from 20 liver experts, and from a Medline search of the literature, items potentially affecting the HRQL of these patients were identified. A separate sample of 75 patients identified which items they found problematic and rated their importance. Results were explored using factor analysis; domains were chosen and items placed within domains. Redundant questions were eliminated and the final questionnaire was pretested in 10 patients. Using this instrument, HRQL was assessed in a further 133 patients with various types and stages of liver disease.
RESULTS—Patients, experts, and the literature search identified 156 items of potential importance. Of these, 35 proved important to over 50% of 75 respondents in the item reduction sample. The factor analysis suggested six domains. After eliminating redundancies, the Chronic Liver Disease Questionnaire (CLDQ) included 29 items in the following domains: fatigue, activity, emotional function, abdominal symptoms, systemic symptoms, and worry. In pretesting, patients found the CLDQ clear and easy to complete in 10 minutes. In another 133 patients, the CLDQ showed a gradient between patients without cirrhosis, Child's A cirrhosis, and those with Child's B or C cirrhosis. CLDQ has evidence for moderate reliability at six months and seems to be responsive.
CONCLUSION—The CLDQ is short, easy to administer, produces both a summary score and domain scores, and correlates with the severity of liver disease.


Keywords: quality of life; liver disease; liver specific quality of life; well being

Full Text

The Full Text of this article is available as a PDF (86.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belle S. H., Porayko M. K., Hoofnagle J. H., Lake J. R., Zetterman R. K. Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD). Liver Transpl Surg. 1997 Mar;3(2):93–104. doi: 10.1002/lt.500030201. [DOI] [PubMed] [Google Scholar]
  2. Bergner M., Bobbitt R. A., Carter W. B., Gilson B. S. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981 Aug;19(8):787–805. doi: 10.1097/00005650-198108000-00001. [DOI] [PubMed] [Google Scholar]
  3. Bergner M. Quality of life, health status, and clinical research. Med Care. 1989 Mar;27(3 Suppl):S148–S156. doi: 10.1097/00005650-198903001-00012. [DOI] [PubMed] [Google Scholar]
  4. Carithers R. L., Jr, Sugano D., Bayliss M. Health assessment for chronic HCV infection: results of quality of life. Dig Dis Sci. 1996 Dec;41(12 Suppl):75S–80S. doi: 10.1007/BF02087879. [DOI] [PubMed] [Google Scholar]
  5. Davis G. L., Balart L. A., Schiff E. R., Lindsay K., Bodenheimer H. C., Jr, Perrillo R. P., Carey W., Jacobson I. M., Payne J., Dienstag J. L. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther. 1994 Mar-Apr;16(2):334–272. [PubMed] [Google Scholar]
  6. Foster G. R., Goldin R. D., Thomas H. C. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998 Jan;27(1):209–212. doi: 10.1002/hep.510270132. [DOI] [PubMed] [Google Scholar]
  7. Fowlie M., Berkeley J. Quality of life--a review of the literature. Fam Pract. 1987 Sep;4(3):226–234. doi: 10.1093/fampra/4.3.226. [DOI] [PubMed] [Google Scholar]
  8. Guyatt G. H., Berman L. B., Townsend M., Pugsley S. O., Chambers L. W. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987 Oct;42(10):773–778. doi: 10.1136/thx.42.10.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guyatt G. H., Bombardier C., Tugwell P. X. Measuring disease-specific quality of life in clinical trials. CMAJ. 1986 Apr 15;134(8):889–895. [PMC free article] [PubMed] [Google Scholar]
  10. Guyatt G. H., Kirshner B., Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol. 1992 Dec;45(12):1341–1345. doi: 10.1016/0895-4356(92)90194-r. [DOI] [PubMed] [Google Scholar]
  11. Guyatt G. H., Townsend M., Berman L. B., Keller J. L. A comparison of Likert and visual analogue scales for measuring change in function. J Chronic Dis. 1987;40(12):1129–1133. doi: 10.1016/0021-9681(87)90080-4. [DOI] [PubMed] [Google Scholar]
  12. Guyatt G., Walter S., Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40(2):171–178. doi: 10.1016/0021-9681(87)90069-5. [DOI] [PubMed] [Google Scholar]
  13. Jaeschke R., Singer J., Guyatt G. H. A comparison of seven-point and visual analogue scales. Data from a randomized trial. Control Clin Trials. 1990 Feb;11(1):43–51. doi: 10.1016/0197-2456(90)90031-v. [DOI] [PubMed] [Google Scholar]
  14. Jaeschke R., Singer J., Guyatt G. H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989 Dec;10(4):407–415. doi: 10.1016/0197-2456(89)90005-6. [DOI] [PubMed] [Google Scholar]
  15. Juniper E. F., Guyatt G. H., Willan A., Griffith L. E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994 Jan;47(1):81–87. doi: 10.1016/0895-4356(94)90036-1. [DOI] [PubMed] [Google Scholar]
  16. Kirshner B., Guyatt G. A methodological framework for assessing health indices. J Chronic Dis. 1985;38(1):27–36. doi: 10.1016/0021-9681(85)90005-0. [DOI] [PubMed] [Google Scholar]
  17. Knechtle S. J., Fleming M. F., Barry K. L., Steen D., Pirsch J. D., D'Alessandro A. M., Kalayoglu M., Belzer F. O. Liver transplantation in alcoholics: assessment of psychological health and work activity. Transplant Proc. 1993 Apr;25(2):1916–1918. [PubMed] [Google Scholar]
  18. Levy M. F., Goldstein R. M., Husberg B. S., Gonwa T. A., Backman L., Abouljoud M., Mulligan D., Klintmalm G. B. Baylor update: outcome analysis in liver transplantation. Clin Transpl. 1993:161–173. [PubMed] [Google Scholar]
  19. Lundgren M., Kristiansson M., Ericzon B. G., Eleborg L. Improved quality of life after liver transplantation. Transplant Proc. 1994 Jun;26(3):1779–1779. [PubMed] [Google Scholar]
  20. Moore K. A., Burrows G., Jones R. M., Hardy K. Control evaluation of cognitive functioning, mood state, and quality of life post-liver transplant. Transplant Proc. 1992 Feb;24(1):202–202. [PubMed] [Google Scholar]
  21. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  22. Tarter R. E., Switala J., Arria A., Plail J., Van Thiel D. Quality of life before and after orthotopic hepatic transplantation. Arch Intern Med. 1991 Aug;151(8):1521–1526. [PubMed] [Google Scholar]
  23. Testa M. A., Simonson D. C. Assesment of quality-of-life outcomes. N Engl J Med. 1996 Mar 28;334(13):835–840. doi: 10.1056/NEJM199603283341306. [DOI] [PubMed] [Google Scholar]
  24. Ware J. E., Jr, Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–483. [PubMed] [Google Scholar]
  25. Wilson I. B., Cleary P. D. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995 Jan 4;273(1):59–65. [PubMed] [Google Scholar]
  26. de Bruin A. F., de Witte L. P., Stevens F., Diederiks J. P. Sickness Impact Profile: the state of the art of a generic functional status measure. Soc Sci Med. 1992 Oct;35(8):1003–1014. doi: 10.1016/0277-9536(92)90240-q. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES